intravenous immunoglobulin resistant kawasaki disease

Authors

mohammad reza navaeifar nosocomial infection research center, mazandaran university of medical sciences, bouali-sina hospital, sari, iran

mohammad sadegh rezai department of pediatric infectious disease, bou ali sina hospital, pasdaran boulevard, sari, iran

abstract

abstract kawasaki disease is a systemic vasculitis that mainly affects younger children. although the definite cause still remains unknown but the clinical and epidemiologic findings discuss an infectious cause. the prevalence of incomplete kawasaki disease reported 15 to 36.2%, and it is more frequent in the extremes of the age spectrum. non delayed treatment of disease should be initiated because of critical cardiac vascular complications. up to 15% - 25% of patients with kawasaki disease who remain febrile after administration of first dose of intravenous immunoglobin plus aspirin are classified as refractory disease. these intravenous immunoglobin resistant cases are at increasing risk for coronary artery complications. the strategy on prediction of potentially non responder and treatment of intravenous immunoglobin resistant patients is now controversial but some useful points were recommended.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Recurrent Kawasaki disease resistant to initial treatment with intravenous immunoglobulin.

Kawasaki disease (mucocutaneous lymph node syndrome) is a disease of unknown etiology characterized by vasculitis which may affect the coronary arteries. Young children are most commonly affected although the disease has been described in adults. Kawasaki disease (KD) was first described by Dr Tomisaku Kawasaki in 1967. Since then, more cases have been reported worldwide, the majority being fro...

full text

Low-dose Methotrexate Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease

PURPOSE The aim of this study was to evaluate the efficacy of low-dose oral methotrexate (MTX) as a treatment for patients with Kawasaki disease (KD) which was resistant to intravenous immunoglobulin (IVIG). PATIENTS AND METHODS The patients who had persistent or recrudescent fever after treatment with IVIG were subsequently treated with low-dose oral MTX [10mg/body surface area (BSA)] once w...

full text

Use of Corticosteroid in Children with Unresponsiveness to Intravenous Immunoglobulin in Kawasaki Disease

Background Kawasaki Disease (KD) is a vasculitis with multi-organ involvementof unknown etiology; it is the most common cause of pediatric-heart diseases in developed countries. Treatment with Intravenous Immunoglobulin (IVIG) prevents coronary artery lesions; although there are some IVIG-resistant cases, combination therapy with corticosteroids and IVIG is one of the recommendations for treatm...

full text

Predictors of Intravenous Immunoglobulin (IVIG) Resistance in Children with Kawasaki Disease in Calabria Region, Italy

Background Kawasaki disease (KD) is the second most common childhood vasculitis and one of the main causes of acquired heart disease in children. Recent work focuses on the early diagnostic importance of those risk factors that indicate resistance to intravenous immunoglobulin (IVIG) treatment. The objectives of this study were to identify clinical, laboratory and/or instrumental factors that c...

full text

Methylprednisolone pulse therapy for massive lymphadenopathy in a child with intravenous immunoglobulin-resistant Kawasaki disease.

Kawasaki disease (KD) is an acute febrile multi-system vasculitis of unknown etiology. The diagnosis is based on clinical features. We describe a case of intravenous immunoglobulins (IVIG)-resistant KD presenting with persistent fever and massive cervical lymphadenopathy associated with mild respiratory distress. The symptoms resolved after methylprednisolone pulse therapy. High-dose pulse ster...

full text

A meta-analysis of re-treatment for intravenous immunoglobulin-resistant Kawasaki disease.

OBJECTIVE To determine the optimal drug therapy for intravenous immunoglobulin-resistant Kawasaki disease. METHODS Studies regarding drug therapy for intravenous immunoglobulin-resistant Kawasaki disease were selected from medical electronic databases including PubMed, Medline, Elsevier, and Springer Link. The effectiveness in terms of temperature recovery and coronary artery damage was compa...

full text

My Resources

Save resource for easier access later


Journal title:
journal of pediatrics review

جلد ۱، شماره ۱، صفحات ۴۴-۵۲

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023